Findings on diabetes and weight loss drugs in hip replacement. Novo Nordisk's Ozempic shows a 44% reduction in joint infections, and Wegovy proves safe, reducing complications.
https://www.marijuanamoment.net/fda-grants-priority-review-of-mdma-assisted-therapy-for-ptsd-psychedelics-drug-development-company-says/ The Food and Drug Administration (FDA) has agreed to review
Gilead Sciences will acquire CymaBay Therapeutics for $4.3 billion, advancing liver disease treatment with seladelpar. FDA priority review was granted, and there is potential for significant revenue growth.
Challenges and updates in the weight loss drug market, as Novo Nordisk and Eli Lilly address supply shortages for Wegovy and Mounjaro. Strategies to meet the increasing demand and potential market projections.
Event features Monogram's mBôs commercial robot alongside panel of orthopaedic surgeonsAUSTIN, TX / ACCESSWIRE / February 12, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical
Cholera is an acute diarrheal illness caused by infection of the intestine with the bacterium Vibrio choleraeCrofelemer previously granted Orphan Drug Designation by the FDA and the EMA for both short bowel syndrome and
The poster presentation includes the first description of Corvus' next-generation ITK inhibitor preclinical product candidates, which were designed to deliver precise T-cell modulation that is optimized for specific
Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced a late-breaking poster presentation at